JERUSALEM, Dec. 16, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai" or the "Company"), a biopharmaceutical company focused on developing ...

SAN JOSE, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Synaptics ® Incorporated (Nasdaq: SYNA) today announced that it is collaborating with Google on Edge AI for the IoT to define the optimal ...

(NASDAQ: PXLW), a leading provider of visual processing solutions, announced that the newly released iQOO Z9 Turbo L smartphone is equipped with Pixelworks' X5 Turbo visual processor. The integration ...

SAN DIEGO and CALGARY, AB, Dec. 18, 2024 /CNW/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the ...

Mumbai (Maharashtra) [India], December 16: Lytus Technologies (NASDAQ: LYT), a forward-thinking platform services entity renowned for its innovation-driven business model, today announced the ...

MELBOURNE, Australia and BRUSSELS, Dec. 31, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) and the Brussels-based Oncidium foundation today announce that ...

NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) has scheduled its fourth quarter and full year 2024 financial results announcement. Senior management will be available for questions ...

The Nasdaq Composite has been gaining ground for more than two years now. Its rise was driven by the dawn of artificial ...

NEW YORK, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) announces that it will observe the passing of President Jimmy Carter by closing all Nasdaq U.S. equities and options markets on ...

The regaining of compliance is a result of the Company's closing bid price of the Company's ordinary shares (the "Shares") being at least $1.00 for at least 10 consecutive business days prior to ...

About MediaPlus Venture Group Pte Ltd: MediaPlus Venture Group Pte Ltd is a Singapore-based firm specializing in web design, ...